As part of the reshuffle, I-Mab will prioritise the advancement of givastomig, a CLDN18.2 x 4-1BB bispecific antibody, ...

I-Mab (IMAB) stock jumped 15% Monday after the biotech company said it plans to focus on developing givastomig for the treatment of gastric cancers. Read more here.

The firm is shifting its resources to fund and expand its Phase I clinical trial of givastomig in CLDN18.2-expressing advanced solid tumor patients.

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving beyond cancer and rare disease.

The division, which will expand on the already-existing Released Soldiers’ Division and Fund, will include a dedicated branch for reservists’ welfare and be led by Col. (res.) Eyal Hans ...

Today has seen a lot of movement in Russia's Kursk region, where Ukraine launched an offensive last year. We'll be back tomorrow with more updates on the war in Ukraine. But here is a look at the ...

The U.S. Congress formally certified Republican President-elect Donald Trump's November election victory over Democratic Vice President Kamala Harris, clearing the way for him to be sworn in on ...

Justin Trudeau announced Monday that he was also stepping down as leader of Canada’s Liberal Party. He will remain in both roles until a replacement is chosen. By Matina Stevis-GridneffIan ...

"We are worried we don't get any eggs. What are we going to do?" said Merie Belluomini, co-owner of San Francisco's Victoria Pastry Company. Mark Kotsay sees a new era ahead for the Athletics, and ...

ROCKVILLE, MD, USA I January 6, 2025 I I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision ...

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...

Vice President Kamala Harris announced Donald Trump’s win in a ritual that was considered ceremonial and uneventful before the Capitol attack in 2021. The Jan. 6 Rioters, 4 Years Later Hundreds ...